AKTX
Akari Therapeutics, Plc
NASDAQHealthcareBiotechnologyGB
Rating:B-
Company Profile
CEO
Abizer Gaslightwala
IPO Date
2014-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Akari Therapeutics, Plc
CEO
Abizer Gaslightwala
IPO Date
2014-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
| 2,473 |
| $0.00 |
| 16 Mar 2026 | Neal James R | director | P-Purchase | Acquired | 3,093 | $0.39 |
| 16 Mar 2026 | Neal James R | director | P-Purchase | Acquired | 3,093 | $0.00 |
| 18 Dec 2025 | Prudo-Chlebosz Raymond | director | P-Purchase | Acquired | 618,658 | $0.39 |
| 18 Dec 2025 | Prudo-Chlebosz Raymond | director | P-Purchase | Acquired | 618,658 | $0.00 |
| 18 Dec 2025 | Prudo-Chlebosz Raymond | director | P-Purchase | Acquired | 386,661 | $0.39 |
| 18 Dec 2025 | Prudo-Chlebosz Raymond | director | P-Purchase | Acquired | 386,661 | $0.00 |
| 18 Dec 2025 | Patel Sandip I | director | P-Purchase | Acquired | 247,462 | $0.39 |
| 18 Dec 2025 | Patel Sandip I | director | P-Purchase | Acquired | 247,462 | $0.00 |